| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/22/1997 | EP0642338B1 USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE |
| 01/22/1997 | CN1141059A P53-binding polypeptides and polynucleotides encoding same |
| 01/22/1997 | CN1141058A In situ modification and manipulation of stem cells of the central nervous system |
| 01/22/1997 | CN1141043A Non-peptide tachykinin receptor antagonists |
| 01/22/1997 | CN1140998A Compositions which inhibit apoptosis, method of purifying the compositions and uses thereof |
| 01/21/1997 | US5596106 Cannabinoid receptor antagonists |
| 01/21/1997 | US5596101 N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 01/21/1997 | US5595997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 01/21/1997 | US5595993 Antischemic piperazinyl- and piperidinyl-cyclohexanes |
| 01/21/1997 | US5595989 Antiinflammatory agents and antidiabetic agents |
| 01/21/1997 | US5595983 Antagonist action at amino acid receptors, anticonvulsants |
| 01/21/1997 | CA2118704C Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists |
| 01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/16/1997 | WO1997001558A1 Novel substituted azabicyclic compounds |
| 01/16/1997 | WO1997001556A1 Novel substituted azacyclic or azabicyclic compounds |
| 01/16/1997 | WO1997001555A1 Novel substituted azacyclic compounds |
| 01/16/1997 | WO1997001554A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | WO1997001553A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | WO1997001551A1 Pyrazole compounds and pharmaceutical compositions |
| 01/16/1997 | WO1997001536A1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | WO1997001352A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | WO1997001351A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 01/16/1997 | WO1997001350A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/16/1997 | DE19525598A1 Schlafmittel Sleeping pills |
| 01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
| 01/16/1997 | CA2226017A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | CA2225691A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | CA2224516A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | CA2224474A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/15/1997 | EP0753506A1 6-Dimethylaminomethyl-1-phenyl-cyclo-hexane compounds as pharmaceutical agents |
| 01/15/1997 | EP0753303A2 Physiologically functional food having brain function-improving, learning ability-enhancing, and memory-enhancing functions |
| 01/15/1997 | EP0753300A1 Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man |
| 01/15/1997 | EP0753296A2 Oral formulations of S(+)-ibuprofen |
| 01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0752994A1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES, THEIR PREPARATION AND DRUGS CONTAINING THEM |
| 01/15/1997 | EP0752993A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752992A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same |
| 01/15/1997 | EP0752991A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752988A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 01/15/1997 | EP0752982A1 Biphenyl derivatives as 5ht1d antagonists |
| 01/15/1997 | EP0752981A1 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists |
| 01/15/1997 | EP0752884A1 Method of treating auto-immune diseases using type one interferons |
| 01/15/1997 | EP0752881A1 A novel brain endothelial cell protein and methods for its use |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752865A1 Use of substituted dextrane for treating nervous system damage, and heparane sulphate-enriched fractions |
| 01/15/1997 | EP0752860A1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 01/15/1997 | EP0752854A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 01/15/1997 | EP0693926B1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 01/15/1997 | EP0584091B1 Benzopyranones, methods of manufacture and use thereof |
| 01/15/1997 | EP0571457B1 Iloprost effective against cerebral malaria |
| 01/15/1997 | EP0495831B1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 01/15/1997 | CN1140454A Novel mercaptoacetylamido-1,3,4,5-tetrahydro-benzo|c¨ azepin-3-one disulfide derivs. useful as inhibitors of enkephalinase and ACE |
| 01/15/1997 | CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase |
| 01/15/1997 | CN1140448A New compounds with analgesic and local anaesthetic effect |
| 01/15/1997 | CN1140411A Oral liquid compositions contg. paroxetine resinate |
| 01/15/1997 | CN1140409A Treatment of normotensive glaucoma with angiotensin II antagonisto |
| 01/15/1997 | CN1140174A Piperidine derivatives, process for preparation thereof and application thereof in therapeutics |
| 01/15/1997 | CN1140171A Benzofurans |
| 01/15/1997 | CN1140167A Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromanes |
| 01/14/1997 | US5594144 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 01/14/1997 | US5594140 Imidazo[1,5-A]quinolines for treatment of anxiety and sleep disorders |
| 01/14/1997 | US5594030 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/14/1997 | US5594024 Centrally actig substituted phenylazacycloalkanes |
| 01/14/1997 | US5594023 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5594019 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles |
| 01/14/1997 | US5594014 Indole derivatives as 5-HT1 agonists |
| 01/14/1997 | US5593995 Treatment of psychoses and psychological disorders; analgesics |
| 01/14/1997 | US5593994 Prostaglandin synthase inhibitors |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593989 Tetracyclic 1,4-oxazine compounds |
| 01/14/1997 | US5593975 Adenosine derivatives having A2 agonist activity |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593882 Selectin variants |
| 01/14/1997 | US5593695 Morphine therapy |
| 01/14/1997 | US5593658 Medical compositions |
| 01/14/1997 | CA2053880C Treatment of motility disorders with a gnrh analog |
| 01/14/1997 | CA1338845C Thiophene 2-carboxamide derivatives and their use as pharmaceuticals |
| 01/14/1997 | CA1338844C Thiophene carboxamine derivatives and their use as pharmaceuticals |
| 01/12/1997 | CA2180085A1 Narcotic antagonist |
| 01/09/1997 | WO1997000864A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | WO1997000863A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | CA2220925A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | CA2220529A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/08/1997 | EP0752421A1 Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 01/08/1997 | EP0751947A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 01/08/1997 | EP0751940A1 Sesquiterpenic derivatives |
| 01/08/1997 | EP0751939A1 Naphthylamides as central nervous system agents |
| 01/08/1997 | EP0751936A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |